ReviewClinical pharmacokinetics2016

Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.

Bing-Bing Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.